ACADIA Pharmaceuticals Stock Price Chart Technical Analysis: Based on the share price being above its 5, 20 & 50 day exponential moving averages. Explore the future of Acadia Pharmaceuticals, Inc. (ACAD) with our AI-driven year stock price prediction. By leveraging cutting-edge algorithms combined with. ACADIA Pharmaceuticals NasdaqGS:ACAD Stock Report ; Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 23 Aug, Based on the Rule 16, the options market is currently suggesting that ACADIA Pharmaceuticals will have an average daily up or down price movement of about %. ACAD EPS for the last quarter is USD despite the estimation of USD. In the next quarter EPS is expected to reach USD. Track more of ACADIA.
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter financial results on Tuesday, August 6, ACAD | Complete ACADIA Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. The average Acadia Pharmaceuticals stock price prediction forecasts a potential upside of % from the current ACAD share price of $ Prediction of stock market is a crucial task and prominent research area in financial domain as investing in stock market involves higher risk. However with. Tomorrow's movement Prediction of Acadia Pharmaceuticals ACAD appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this. ACAD is a stock in Health Care which has been forecasted to be worth $ as an average. On the higher end, the forecast price is $ USD by jason butler. ACADIA Pharmaceuticals (ACAD) has a Smart Score of 7 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Browse our live Acadia stock chart to get all the information you need on Acadia stock price today Acadia Pharmaceuticals Inc. Spread (as low as). Our common stock is listed on The NASDAQ Global Select Market under the symbol “ACAD”. prediction as to the direction or magnitude of any effect that. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical. Acadia Pharmaceuticals Inc Stock (ACAD) is expected to reach an average price of $ in , with a high forecast of $ and a low forecast of $
Tomorrow's movement Prediction of ACADIA Pharmaceuticals Inc. ACAD appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. ACADIA Pharmaceuticals has received a consensus rating of Moderate Buy. The company's average rating score is , and is based on 11 buy ratings. Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of $ per share, beating the Zacks Consensus Estimate of $ per share. Track Acadia Pharmaceuticals Inc (ACAD) Stock Price, Quote, latest community messages, chart, news and other stock related information. The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction. View ACADIA Pharmaceuticals Inc. ACAD stock quote prices, financial information, real-time forecasts, and company news from CNN. The 19 analysts with month price forecasts for ACAD stock have an average target of , with a low estimate of 19 and a high estimate of The average. ACAD Comments Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your.
ACADIA Pharmaceuticals's stock was trading at $ on May 7, a day before the last earnings report was released. Following the release of the earnings. EPS is expected to grow by % per annum. Return on equity is forecast to be % in 3 years. ACAD stock results show that ACADIA Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of [9/24/] Vertex Pharmaceuticals (VRTX) Stock Price Forecast ACADIA Pharmaceuticals: With Return Forecast Of 84%, ACADIA Pharmaceuticals Is A Better Bet. Investing in growth stocks can be very risky. If the company such as ACADIA Pharmaceuticals does not do well, investors take a loss on the stock when it is time.
prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common stock. The underwriters. Harmony Biosciences Holdings has an average 1 year price target of $, an upside of % from Harmony Biosciences Holdings's current stock price of $ Explore the potential upside of Acadia Pharmaceuticals stock! Cramer predicts its worth could exceed $ billion with FDA approval. See ACADEMEDIA AB stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.
Best Indicators For Trading Options | What Does Lg Tv Stand For